Page 127 - 南京医科大学自然版

第46卷第4期 梅健文，马 啸，王朝霞. 线粒体代谢在肿瘤耐药中的研究进展［J］.
2026年4月 南京医科大学学报（自然科学版），2026，46（4）：587-597 ·595 ·

circumvent nutrient limitations and maintain immune sup⁃ dimer⁃interface mutations［J］. Nature，2018，559（7712）：
pression［J］. Nat Commun，2018，9（1）：5099 125-129
R132H
［14］GAO Y Y，ZHENG H. Role of mitochondria and potential ［27］KIM G H，CHOI S Y，OH T I，et al. IDH1 causes resis⁃
of mitochondria⁃targeted therapy in BRAF mutant cancer： tance to HDAC inhibitors by increasing NANOG in glio⁃
a review［J］. Crit Rev Oncol Hematol，2024，203：104484 blastoma cells［J］. Int J Mol Sci，2019，20（11）：2679
［15］LEI T Y，XU T W，ZHANG N，et al. Anlotinib combined ［28］WU J Y，HUANG T W，HSIEH Y T，et al. Cancer⁃derived
with osimertinib reverses acquired osimertinib resistance succinate promotes macrophage polarization and cancer
in NSCLC by targeting the c ⁃ MET/MYC/AXL axis［J］. metastasis via succinate receptor［J］. Mol Cell，2020，77
Pharmacol Res，2023，188：106668 （2）：213-227
［16］DEL VECCHIO V，REHMAN A，PANDA S K，et al. Mito⁃ ［29］HUA W，TEN DIJKE P，KOSTIDIS S，et al. TGFβ ⁃ in⁃
chondrial transfer from adipose stem cells to breast can⁃ duced metabolic reprogramming during epithelial⁃to⁃mes⁃
cer cells drives multi⁃drug resistance［J］. J Exp Clin Can⁃ enchymal transition in cancer［J］. Cell Mol Life Sci，
cer Res，2024，43（1）：166 2020，77（11）：2103-2123
［17］LU S J，TIAN H L，LI B W，et al. An ellagic acid coordi⁃ ［30］HARDING J J，LOWERY M A，SHIH A H，et al. Isoform
nated copper⁃based nanoplatform for efficiently overcom⁃ switching as a mechanism of acquired resistance to mu⁃
ing cancer chemoresistance by cuproptosis and synergis⁃ tant isocitrate dehydrogenase inhibition［J］. Cancer Dis⁃
tic inhibition of cancer cell stemness［J］. Small，2024，20 cov，2018，8（12）：1540-1547
（17）：e2309215 ［31］WANG Y G，LIU H H，CAO Y T，et al. The role of mito⁃
［18］WANG P L，KE B，MA G. Drug⁃tolerant persister cancer chondrial dynamics and mitophagy in carcinogenesis，me⁃
cells［J］. J Natl Cancer Cent，2024，4（1）：1-5 tastasis and therapy［J］. Front Cell Dev Biol，2020，8：
［19］HUANG H H，ZHANG S Y，LI Y Y，et al. Suppression of 413
mitochondrial ROS by prohibitin drives glioblastoma pro⁃ ［32］BAUMGARTNER V，SCHAER D，MOCH H，et al. Mito⁃
gression and therapeutic resistance［J］. Nat Commun， chondrial elongation and ROS⁃mediated apoptosis in pros⁃
2021，12（1）：3720 tate cancer cells under therapy with apalutamide and com⁃
［20］XU Y J，GAO W N，ZHANG Y，et al. ABT737 reverses plex I inhibitor［J］. Int J Mol Sci，2024，25（13）：6939
cisplatin resistance by targeting glucose metabolism of hu⁃ ［33］YU Y，PENG X D，QIAN X J，et al. Fis1 phosphorylation
man ovarian cancer cells［J］. Int J Oncol，2018，53（3）： by Met promotes mitochondrial fission and hepatocellular

1055-1068 carcinoma metastasis［J］. Signal Transduct Target Ther，
［21］PASSANITI A，KIM M S，POLSTER B M，et al. Targeting 2021，6（1）：401
mitochondrial metabolism for metastatic cancer therapy［J］. ［34］HE X，ZHONG L，WANG N，et al. Gastric cancer actively
Mol Carcinog，2022，61（9）：827-838 remodels mechanical microenvironment to promote che⁃
［22］CHENG A N，CHENG L C，KUO C L，et al. Mitochondrial motherapy resistance via MSCs ⁃ mediated mitochondrial
lon⁃induced mtDNA leakage contributes to PD⁃L1⁃mediat⁃ transfer［J］. Adv Sci（Weinh），2024，11（47）：e2404994
ed immunoescape via STING⁃IFN signaling and extracel⁃ ［35］LEI X Y，LIN H，WANG J Q，et al. Mitochondrial fission
lular vesicles［J］. J Immunother Cancer，2020，8（2）： induces immunoescape in solid tumors through decreas⁃
e001372 ing MHC⁃I surface expression［J］. Nat Commun，2022，13
［23］SALAROGLIO I C，BELISARIO D C，AKMAN M，et al. （1）：3882
Mitochondrial ROS drive resistance to chemotherapy and ［36］PARK J D，KIM K S，CHOI S H，et al. ELK3 modulates
immune⁃killing in hypoxic non⁃small cell lung cancer［J］. the antitumor efficacy of natural killer cells against triple
J Exp Clin Cancer Res，2022，41（1）：243 negative breast cancer by regulating mitochondrial dyna⁃
［24］ZHAO J C，AGARWAL S，AHMAD H，et al. A review of mics［J］. J Immunother Cancer，2022，10（7）：e004825
FLT3 inhibitors in acute myeloid leukemia［J］. Blood ［37］SAITO K，ZHANG Q，YANG H，et al. Exogenous mito⁃
Rev，2022，52：100905 chondrial transfer and endogenous mitochondrial fission
［25］AKIYAMA H，ZHAO R，OSTERMANN L B，et al. Mito⁃ facilitate AML resistance to OXPHOS inhibition［J］.
chondrial regulation of GPX4 inhibition⁃mediated ferrop⁃ Blood Adv，2021，5（20）：4233-4255
tosis in acute myeloid leukemia［J］. Leukemia，2024，38 ［38］WANG S K，CHENG H X，LI M M，et al. BNIP3⁃mediat⁃
（4）：729-740 ed mitophagy boosts the competitive growth of lenvatinib⁃
［26］INTLEKOFER A M，SHIH A H，WANG B，et al. Ac⁃ resistant cells via energy metabolism reprogramming in
quired resistance to IDH inhibition through trans or Cis HCC［J］. Cell Death Dis，2024，15（7）：484